RO5503781
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RO5503781, covering 2015-08-18 to 2017-01-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia [Phase 1]